TLR4 and breast cancer: Induced M1 macrophage polarization from M0 type via the TLR4/NF-κB/MAPK pathway; enhanced TNF-α and IL-12 secretion, inhibited breast cancer cell proliferation and angiogenesis through the IL-12/VEGF axis, thereby suppressed tumor growth and angiogenesis